Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Laurence Chan

Concepts (111)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Kidney Transplantation
10
2015
576
1.270
Why?
Immunosuppressive Agents
9
2015
682
0.950
Why?
Graft Rejection
8
2015
548
0.920
Why?
Isoantibodies
5
2014
57
0.910
Why?
Tacrolimus
3
2015
149
0.770
Why?
Sirolimus
3
2010
195
0.710
Why?
Boronic Acids
2
2010
35
0.690
Why?
Pyrazines
2
2010
72
0.670
Why?
Pancreas Transplantation
4
2011
64
0.580
Why?
HLA Antigens
4
2011
223
0.580
Why?
Graft Survival
5
2014
497
0.520
Why?
Kidney Failure, Chronic
2
2010
516
0.460
Why?
Sphingosine
1
2012
33
0.420
Why?
Chemotaxis, Leukocyte
1
2012
131
0.410
Why?
Immunologic Factors
1
2012
224
0.360
Why?
Reperfusion Injury
1
2012
272
0.350
Why?
T-Lymphocytes, Regulatory
1
2012
357
0.340
Why?
Protease Inhibitors
1
2010
101
0.340
Why?
Ischemia
1
2012
370
0.340
Why?
Transplantation, Homologous
2
2011
412
0.330
Why?
Kidney Tubules, Collecting
1
2008
27
0.320
Why?
Kidney Medulla
1
2008
32
0.320
Why?
Enzymes
1
2008
66
0.310
Why?
Kidney
2
2012
1351
0.300
Why?
Acute Kidney Injury
1
2012
705
0.260
Why?
Tissue Donors
4
2011
334
0.240
Why?
Histocompatibility
2
2014
27
0.220
Why?
Energy Metabolism
1
2008
762
0.220
Why?
Proteomics
1
2008
850
0.210
Why?
Immunoglobulins, Intravenous
2
2014
128
0.190
Why?
Bortezomib
2
2010
42
0.180
Why?
Everolimus
2
2010
64
0.170
Why?
Living Donors
2
2010
318
0.140
Why?
Drug Therapy, Combination
2
2010
964
0.140
Why?
Biopsy
2
2010
1078
0.130
Why?
Tremor
1
2015
46
0.130
Why?
Time Factors
7
2014
6368
0.110
Why?
Middle Aged
7
2015
27514
0.100
Why?
Male
10
2015
57479
0.100
Why?
Creatinine
2
2011
491
0.090
Why?
Proteasome Inhibitors
1
2010
43
0.090
Why?
Antilymphocyte Serum
1
2009
66
0.090
Why?
Proteasome Endopeptidase Complex
1
2010
139
0.090
Why?
Cadaver
1
2010
327
0.090
Why?
Antibodies
1
2011
381
0.080
Why?
Immunity, Humoral
1
2010
117
0.080
Why?
Osmotic Pressure
1
2008
31
0.080
Why?
Electrophoresis, Gel, Two-Dimensional
1
2008
104
0.080
Why?
Cyclosporine
1
2009
173
0.080
Why?
Saline Solution, Hypertonic
1
2008
42
0.080
Why?
Chronic Disease
2
2014
1631
0.080
Why?
Microscopy, Electron, Transmission
1
2008
139
0.080
Why?
Adult
6
2015
31327
0.080
Why?
Treatment Outcome
5
2015
9319
0.080
Why?
Phosphates
1
2008
166
0.070
Why?
Female
8
2015
61268
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2008
240
0.070
Why?
Young Adult
3
2015
10731
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
980
0.070
Why?
Blotting, Western
1
2008
1186
0.070
Why?
Amino Acids
1
2008
462
0.060
Why?
Postoperative Complications
1
2015
2230
0.060
Why?
Adaptation, Physiological
1
2008
501
0.060
Why?
Polymers
1
2008
482
0.060
Why?
Glucose
1
2008
940
0.060
Why?
Cell Line
1
2008
2693
0.050
Why?
Mitochondria
1
2008
785
0.050
Why?
Humans
9
2015
118268
0.050
Why?
Animals
4
2012
33152
0.050
Why?
Cell Proliferation
1
2008
2262
0.050
Why?
Acute Disease
2
2014
933
0.050
Why?
Phenotype
1
2008
2937
0.050
Why?
Kaplan-Meier Estimate
2
2011
840
0.040
Why?
Glomerular Filtration Rate
2
2011
681
0.040
Why?
Area Under Curve
1
2015
293
0.030
Why?
Delayed-Action Preparations
1
2015
161
0.030
Why?
Drug Administration Schedule
1
2015
734
0.030
Why?
Patient Selection
2
2009
670
0.030
Why?
Prospective Studies
2
2015
6443
0.030
Why?
Mice
1
2008
15446
0.030
Why?
Colorado
2
2011
4178
0.020
Why?
Monitoring, Immunologic
1
2011
22
0.020
Why?
Transplantation Tolerance
1
2011
31
0.020
Why?
Histocompatibility Testing
1
2011
121
0.020
Why?
Retrospective Studies
3
2014
12932
0.020
Why?
HLA-D Antigens
1
2009
36
0.020
Why?
Prostaglandins A
1
2009
8
0.020
Why?
Urinalysis
1
2009
68
0.020
Why?
Histocompatibility Antigens Class I
1
2009
174
0.020
Why?
Rabbits
1
2009
779
0.020
Why?
Linear Models
1
2011
817
0.020
Why?
Rats, Wistar
1
2009
396
0.020
Why?
Flow Cytometry
1
2011
1072
0.020
Why?
Reoperation
1
2009
557
0.020
Why?
Risk
1
2009
849
0.020
Why?
Magnetic Resonance Spectroscopy
1
2009
505
0.020
Why?
Survivors
1
2009
411
0.020
Why?
Predictive Value of Tests
1
2011
1857
0.020
Why?
Survival Rate
1
2009
1716
0.020
Why?
Dose-Response Relationship, Drug
1
2009
1937
0.020
Why?
Aged, 80 and over
1
2015
6541
0.010
Why?
Mass Screening
1
2011
1048
0.010
Why?
Patient Discharge
1
2009
791
0.010
Why?
Oxidative Stress
1
2009
1167
0.010
Why?
Risk Assessment
1
2011
3043
0.010
Why?
Follow-Up Studies
1
2009
4575
0.010
Why?
Biomarkers
1
2011
3568
0.010
Why?
Rats
1
2009
5339
0.010
Why?
Risk Factors
1
2011
8958
0.010
Why?
Aged
1
2015
19599
0.010
Why?
Adolescent
1
2015
18364
0.010
Why?
Chan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)